Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: OGS stock price vs SRE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SRE's multiple
Needs SRE P/E.
Implied fair value · at OGS's multiple
Needs OGS P/E.
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ONE Gas, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
SEMPRA · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe OGS can materially improve operating margins and close the EBITDA/net margin gap toward Sempra (currently 22.8% vs 60.9% EBITDA margin and 8.6% vs 21.7% net margin), then consider buying because current P/E parity (19.8x vs 19.7x) implies little downside and margin expansion would justify multiple re-rating; otherwise, maintain or sell because the stock already trades at SRE-implied price ($76.97) with limited upside (-0.3%).
On a P/E basis OGS is nearly identical to Sempra (19.8x vs 19.7x) and SRE-implied price ($76.97) is essentially the current price ($77.23), implying no meaningful premium or discount. However on revenue and sales multiples OGS appears cheaper (P/S 1.8x vs 4.3x; EV/Revenue 2.7x vs 6.7x), while EV/EBITDA is slightly higher (11.9x vs 10.9x). The stock sits near the lower end of its historical band ($69.51 - $84.95) and at the bottom of SRE-implied range ($76.97 - $185.09).
Supporting Metrics
